Edesa Biotech (EDSA) Interest Expenses (2013 - 2026)
Edesa Biotech (EDSA) posted Interest Expenses of $101172.0 for Q4 2025, little changed sequentially from $101172.0 in Q2 2025, and little changed YoY from $101172.0 in Q4 2024.
Edesa Biotech (EDSA) Interest Expenses (2013 - 2026) Analysis & Trends
Edesa Biotech has reported Interest Expenses for 13 years, with the latest figure at $101172.0 in Q4 2025.
- Quarterly Interest Expenses changed 0.0% year-over-year to $101172.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $101172.0 (changed 0.0% YoY) and the FY2025 annual result came in at $1.5 million, down 91.86% from the prior year.
- Interest Expenses held at $101172.0 in Q4 2025 per EDSA's latest filing, from $101172.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $15.1 million in Q3 2022 and troughed at $77954.0 in Q3 2024.
- A 5-year average of $2.8 million and a median of $1.7 million in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2021 and 2023: Interest Expenses soared 26163.93% in 2021, then sank 99.48% in 2023.
- Over 5 years, Interest Expenses stood at $101172.0 in 2021, then soared by 1654.77% to $1.8 million in 2022, then fell by 5.7% to $1.7 million in 2023, then slumped by 93.96% to $101172.0 in 2024, then changed by 0.0% to $101172.0 in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered $101172.0, $101172.0, and $101172.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Edesa Biotech | 40.44 Mn | 40.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 168,089.00 |
| Jun 30, 2026 | 168,089.00 |
| Dec 31, 2025 | 101,172.00 |
| Dec 31, 2025 | 101,172.00 |
| Jun 30, 2025 | 101,172.00 |
| Jun 30, 2025 | 101,172.00 |
| Mar 31, 2025 | 101,172.00 |
| Mar 31, 2025 | 101,172.00 |
| Dec 31, 2024 | 101,172.00 |
| Dec 31, 2024 | 101,172.00 |
| Sep 30, 2024 | 77,954.00 |
| Sep 30, 2024 | 77,954.00 |
| Jun 30, 2024 | 101,172.00 |
| Jun 30, 2024 | 101,172.00 |
| Mar 31, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 79,222.00 |
| Sep 30, 2023 | 79,222.00 |